Mastodawn

SalGal Jan 11, 2024

An interesting read in Double Blind today is a reminder of how grateful I am for the pioneering work of "Sasha" Shulgin and all the past/present medicinal chemists. It's exciting to be on the cusp of a more comprehensive and nuanced approach to assessing the risks and benefits of psychedelic compounds! That is my kind of Moxie!

https://doubleblindmag.com/what-is-moxy/

#Psychedelics #Shulgin #DailyGratitude #Moxy

Meet Moxy: The Novel Psychedelic the DEA Tried To Ban

Psychedelics have once again entered public consciousness. The rekindling of interest hasn’t stopped at magic mushrooms and LSD. The Western psychedelic

DoubleBlind Mag

Matt Baggott Oct 12, 2023

I published a thing! This open access article is the result of my years-long attempt to make sense of the history of STP, a psychedelic amphetamine drug that Owsley infamously released in high dose tablets in 1967 San Francisco. STP or DOM is the drug that Sasha Shulgin called "his problem child," echoing Hofmann's label for LSD. Owsley's release of DOM resulted in a lot of bad trips and almost ended Sasha's then-nascent career. Although it overwhelmed a lot of people, DOM wasn't purely negative. Along with nitrous oxide, DOM is one of the distinct pharmacological influences on the Dead's Aoxomoxoa.

https://hopp.uwpress.org/content/65/1/93

Abstract: In 1967, a synthetic psychedelic drug, nicknamed STP, escaped from the archives of Dow Chemical and flooded the Haight-Ashbury neighborhood of San Francisco. The resulting public health crisis can be seen as a case study in how new unsanctioned psychoactive substances become legible to society through the efforts of different actors. STP was interpreted by young hip doctors, underground chemists, and the users themselves. While the first group achieved recognition as experts, the others were largely omitted from media reports on the drug. This article brings together contemporary media reports, pharmacology, and first-person accounts to explore how STP came to be understood as a dangerous drug. As psychedelics gain renewed attention, it is timely to use historic events like the STP crisis to understand how knowledge of new drugs is formed and what sources are recognized or overlooked in the process.

#DrugNerds #Psychedelics #Shulgin #owsley #gratefuldead

Learning about STP

In 1967, a synthetic psychedelic drug, nicknamed STP, escaped from the archives of Dow Chemical and flooded the Haight-Ashbury neighborhood of San Francisco. The resulting public health crisis can be seen as a case study in how new unsanctioned psychoactive substances become legible to society through the efforts of different actors. STP was interpreted by young hip doctors, underground chemists, and the users themselves. While the first group achieved recognition as experts, the others were largely omitted from media reports on the drug. This article brings together contemporary media reports, pharmacology, and first-person accounts to explore how STP came to be understood as a dangerous drug. As psychedelics gain renewed attention, it is timely to use historic events like the STP crisis to understand how knowledge of new drugs is formed and what sources are recognized or overlooked in the process.

History of Pharmacy and Pharmaceuticals

ĸurth Jun 18, 2023

adorable #shulgin

AdeptVeritatis Mar 22, 2023

Today would have been the birthday of Ann #Shulgin.

Thanks for all your work!

ĸurth Mar 11, 2023

Oh ach was, die damals noch nicht unters BTMG fallende Substanz 2-CB wurde bis Ende der 1990er Jahre von der Leipziger Firma ›Drittewelle‹ als Aphrodisiakum ›Erox‹ bzw ›Nexus‹ verkauft. Wildwest 90er zone